OrthoPediatrics, a $98m producer of implants and devices that treat orthopedic conditions in children, is acquiring Canada-based Pega Medical, a developer of implant systems that treat bony deformities in children with osteogenesis imperfecta (brittle bone disease), for $33m. The acquisition adds to OrthoPediatrics’ range of technologies...
Read More
Biosynth Carbosynth, a provider of life science research products and contract manufacturing services, has purchased Ireland-based Aalto Bio Reagents, a supplier of biological materials serving the in-vitro diagnostic (IVD) and vaccine development markets. In March 2022, Biosynth acquired vivitide, a provider of custom peptides and...
Read More
The Walden Group is pleased to provide access to its Q1 2022 Strategic Healthcare M&A Report, which includes:
Market Overview
Major M&A Deals by Sector
What the Leading CEOs are Saying
Performance of Leading Healthcare Companies
Analysis of More Than 50 Q1 M&A...
Read More
The Walden Group is pleased to announce that it was engaged by Katalyst Surgical, LLC and initiated its merger with an affiliate of Carl Zeiss Meditec AG, one of the world’s leading medical technology companies traded on the German Stock Exchange.
Katalyst Surgical is a leader in vitreoretinal instruments, fiberoptic illumination, innovative...
Read More
Integer Holdings Corporation, a $1.2b device outsource manufacturer has acquired Ireland-based Aran Biomedical, a producer of proprietary medical textiles, high precision biomaterial coverings and coatings and advanced metal and polymer braiding for implantable devices. Aran Biomedical enables Integer to penetrate high growth cardiovascular...
Read More